ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRO – QNT Press Release


NEW YORK, June 11, 2022 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ:SPRO) between October 28, 2021 and May 2, 2022both dates inclusive (the “Class Period”), of the important than July 25, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Spero Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Spero Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=6561 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit …

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center